25 min listen
Unavailable
Currently unavailable
Diabetes Core Update: Covid-19 and Diabetes – Considerations for Health Care Professionals - April 2019
Currently unavailable
Diabetes Core Update: Covid-19 and Diabetes – Considerations for Health Care Professionals - April 2019
ratings:
Length:
24 minutes
Released:
Apr 23, 2020
Format:
Podcast episode
Description
Diabetes Core Update: Covid-19 and Diabetes – Considerations for Health Care Professionals - April 2019 This special issue is an audio version of the American Diabetes Associations Covid-19 leadership team discussing a range of issues on Covid-19 and Diabetes. Recorded March 31, 2020. Topics include: Access to medications Effect on Diabetes Self-management Can Patients take their own Supplies if they are an inpatient in the hospital – particularly insulin pumps and CGM Considerations for Specific Hypoglycemic Medications during Inpatient Hospitalization Differences in Management for Persons with Type 1 and Type 2 Diabetes SGLT-2 inhibitors and GLP-1 Receptor Agonists use During Covid-19 Infection Diabetes and Cardiovascular Disease during Covid-19 ACEs and ARBs Stress among Healthcare Professionals Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting. Presented by: Robert Eckel, MD ADA President, Medicine & Science University of Colorado Mary de Groot, PhD ADA President, Health Care & Education Indiana University Irl Hirsch, MD University of Washington Anne Peters, MD University of Southern California Louis Philipson, MD, PhD ADA Past President, Medicine & Science University of Chicago Neil Skolnik, MD Abington Jefferson Health
Released:
Apr 23, 2020
Format:
Podcast episode
Titles in the series (100)
Diabetes Core Update: SGLT-2 inhibitors – Cardiovascular Effects– Sept. 2020: In this first episode of a three-part series on SGLT-2 inhibitors Drs. John Russell and Neil Skolnik discuss the Cardiovascular Outcome Trials (CVOTs) of the SGLT-2 inhibitors, as well as the place of the SGLT-2is in the American Diabetes Association... by Diabetes Core Update